A citation-based method for searching scientific literature

Marc D Ryser, Mathias Worni, Elizabeth L Turner, Jeffrey R Marks, Rick Durrett, E Shelley Hwang. J Natl Cancer Inst 2015
Times Cited: 38







List of co-cited articles
162 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
196
57

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
185
50

Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study.
Yasuaki Sagara, Melissa Anne Mallory, Stephanie Wong, Fatih Aydogan, Stephen DeSantis, William T Barry, Mehra Golshan. JAMA Surg 2015
109
39

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Steven A Narod, Javaid Iqbal, Vasily Giannakeas, Victoria Sopik, Ping Sun. JAMA Oncol 2015
325
31

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
225
31

The natural history of ductal carcinoma in situ of the breast: a review.
Bircan Erbas, Elena Provenzano, Jane Armes, Dorota Gertig. Breast Cancer Res Treat 2006
214
28

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).
E Shelley Hwang, Terry Hyslop, Thomas Lynch, Elizabeth Frank, Donna Pinto, Desiree Basila, Deborah Collyar, Antonia Bennett, Celia Kaplan, Shoshana Rosenberg,[...]. BMJ Open 2019
98
28

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
372
26


Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
Mathias Worni, Igor Akushevich, Rachel Greenup, Deba Sarma, Marc D Ryser, Evan R Myers, E Shelley Hwang. J Natl Cancer Inst 2015
111
21

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
318
18

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.
Lawrence J Solin, Robert Gray, Lorie L Hughes, William C Wood, Mary Ann Lowen, Sunil S Badve, Frederick L Baehner, James N Ingle, Edith A Perez, Abram Recht,[...]. J Clin Oncol 2015
158
18

Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ.
Anna F Meyerson, Juan N Lessing, Kaoru Itakura, Nola M Hylton, Dulcy E Wolverton, Bonnie N Joe, Laura J Esserman, E Shelley Hwang. Breast 2011
17
41

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
444
18


Characterizing the impact of 25 years of DCIS treatment.
Elissa M Ozanne, Yiwey Shieh, James Barnes, Colleen Bouzan, E Shelley Hwang, Laura J Esserman. Breast Cancer Res Treat 2011
71
18

Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data.
Arnaud Seigneurin, Olivier François, José Labarère, Pierre Oudeville, Jean Monlong, Marc Colonna. BMJ 2011
34
17

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.
Beryl McCormick, Kathryn Winter, Clifford Hudis, Henry Mark Kuerer, Eileen Rakovitch, Barbara L Smith, Nour Sneige, Jennifer Moughan, Amit Shah, Isabelle Germain,[...]. J Clin Oncol 2015
232
15

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
388
15

The LORIS Trial: Addressing overtreatment of ductal carcinoma in situ.
A Francis, L Fallowfield, D Rea. Clin Oncol (R Coll Radiol) 2015
52
15

Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
Melissa Pilewskie, Michelle Stempel, Hope Rosenfeld, Anne Eaton, Kimberly J Van Zee, Monica Morrow. Ann Surg Oncol 2016
54
15

Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
Stephen W Duffy, Amanda Dibden, Dimitrios Michalopoulos, Judith Offman, Dharmishta Parmar, Jacquie Jenkins, Beverley Collins, Tony Robson, Suzanne Scorfield, Kathryn Green,[...]. Lancet Oncol 2016
76
15

The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
P A van Luijt, E A M Heijnsdijk, J Fracheboud, L I H Overbeek, M J M Broeders, J Wesseling, G J den Heeten, H J de Koning. Breast Cancer Res 2016
41
15

Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ.
Anthony J Maxwell, Karen Clements, Bridget Hilton, David J Dodwell, Andrew Evans, Olive Kearins, Sarah E Pinder, Jeremy Thomas, Matthew G Wallis, Alastair M Thompson. Eur J Surg Oncol 2018
40
15

Cancer Outcomes in DCIS Patients Without Locoregional Treatment.
Marc D Ryser, Donald L Weaver, Fengmin Zhao, Mathias Worni, Lars J Grimm, Roman Gulati, Ruth Etzioni, Terry Hyslop, Sandra J Lee, E Shelley Hwang. J Natl Cancer Inst 2019
34
17

Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.
M-F Yen, L Tabár, B Vitak, R A Smith, H-H Chen, S W Duffy. Eur J Cancer 2003
99
13

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Laura C Collins, Rulla M Tamimi, Heather J Baer, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2005
173
13

Concordance between vacuum assisted biopsy and postoperative histology: implications for the proposed Low Risk DCIS Trial (LORIS).
S Soumian, E T Verghese, M Booth, N Sharma, S Chaudhri, S Bradley, S Umranikar, R A Millican-Slater, A M Hanby, A Francis. Eur J Surg Oncol 2013
33
15

Breast cancer precursors revisited: molecular features and progression pathways.
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
188
13



Long-term follow-up of in situ carcinoma of the breast.
V Eusebi, E Feudale, M P Foschini, A Micheli, A Conti, C Riva, S Di Palma, F Rilke. Semin Diagn Pathol 1994
215
13

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Mila Donker, Saskia Litière, Gustavo Werutsky, Jean-Pierre Julien, Ian S Fentiman, Roberto Agresti, Philippe Rouanet, Christine Tunon de Lara, Harry Bartelink, Nicole Duez,[...]. J Clin Oncol 2013
211
10

Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
Udo Rudloff, Lindsay M Jacks, Jessica I Goldberg, Christine A Wynveen, Edi Brogi, Sujata Patil, Kimberly J Van Zee. J Clin Oncol 2010
202
10

Detection of ductal carcinoma in situ in women undergoing screening mammography.
Virginia L Ernster, Rachel Ballard-Barbash, William E Barlow, Yingye Zheng, Donald L Weaver, Gary Cutter, Bonnie C Yankaskas, Robert Rosenberg, Patricia A Carney, Karla Kerlikowske,[...]. J Natl Cancer Inst 2002
424
10


Intraductal carcinoma of the breast: follow-up after biopsy only.
D L Page, W D Dupont, L W Rogers, M Landenberger. Cancer 1982
477
10

National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009.
Carmen J Allegra, Denise R Aberle, Pamela Ganschow, Stephen M Hahn, Clara N Lee, Sandra Millon-Underwood, Malcolm C Pike, Susan D Reed, Audrey F Saftlas, Susan A Scarvalone,[...]. J Natl Cancer Inst 2010
152
10

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
323
10

Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data.
Harry J de Koning, Gerrit Draisma, Jacques Fracheboud, Arry de Bruijn. Breast Cancer Res 2006
32
12


Interpreting overdiagnosis estimates in population-based mammography screening.
Rianne de Gelder, Eveline A M Heijnsdijk, Nicolien T van Ravesteyn, Jacques Fracheboud, Gerrit Draisma, Harry J de Koning. Epidemiol Rev 2011
135
10

Cancer statistics: Breast cancer in situ.
Elizabeth M Ward, Carol E DeSantis, Chun Chieh Lin, Joan L Kramer, Ahmedin Jemal, Betsy Kohler, Otis W Brawley, Ted Gansler. CA Cancer J Clin 2015
140
10

A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Eileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, Frederick L Baehner, Refik Saskin, Steven M Butler, Alan Tuck, Sandip Sengupta, Leela Elavathil, Prashant A Jani,[...]. Breast Cancer Res Treat 2015
138
10

Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Emma J Groen, Lotte E Elshof, Lindy L Visser, Emiel J Th Rutgers, Hillegonda A O Winter-Warnars, Esther H Lips, Jelle Wesseling. Breast 2017
77
10

Surgery versus monitoring and endocrine therapy for low-risk DCIS: The COMET Trial.
Linda M Youngwirth, Judy C Boughey, E Shelley Hwang. Bull Am Coll Surg 2017
34
11

Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials.
Lars J Grimm, Marc D Ryser, Ann H Partridge, Alastair M Thompson, Jeremy S Thomas, Jelle Wesseling, E Shelley Hwang. Ann Surg Oncol 2017
48
10

Ductal carcinoma in situ: to treat or not to treat, that is the question.
Maartje van Seijen, Esther H Lips, Alastair M Thompson, Serena Nik-Zainal, Andrew Futreal, E Shelley Hwang, Ellen Verschuur, Joanna Lane, Jos Jonkers, Daniel W Rea,[...]. Br J Cancer 2019
69
10

Ductal carcinoma in situ: treatment or active surveillance?
Henry M Kuerer. Expert Rev Anticancer Ther 2015
15
20

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
John F Forbes, Ivana Sestak, Anthony Howell, Bernardo Bonanni, Nigel Bundred, Christelle Levy, Gunter von Minckwitz, Wolfgang Eiermann, Patrick Neven, Michael Stierer,[...]. Lancet 2016
91
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.